Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121184 · ClinicalTrials.gov registry record · NA
Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes
A NA study, sponsored by Northwestern University.
- Terminated
- Registry status
- NA
- Development phase
- 172
- Enrollment target
NCT02121184: Clinical Trial NA study, sponsored by Northwestern University.
NCT02121184 is a NA study that was terminated before completion, run by Northwestern University. The registered enrollment target is 172 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121184, a NA study, was terminated before completion, sponsored by Northwestern University.
- TERMINATED
- Registry status
- NA
- Development phase
- 172 participants
- Enrollment target
Study Summary
Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables which could affect fetal heart rate patterns at the time of initiation of analgesia, such as fluid administration and oxytocin management, could help us provide better care for our patients and their fetuses. Hypotheses: Patients who receive a 1000 mL fluid bolus and lower rates of oxytocin administration will have fewer non-reassuring fetal heart rate (FHR) changes.
Primary Outcome
Incidence of non-reassuring fetal heart rate tracings during the first 60 minutes after the placement of epidural analgesia
Interventions
- DRUG Routine oxytocin
- DRUG Half-dose oxytocin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2014-04 |
| Est. Completion | 2021-09-21 |
| Phase | NA |
Why NCT02121184 stopped before completion
NCT02121184 is an interventional study that assigns participants to a tested intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Routine oxytocin is the first listed.
NCT02121184 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02121184 about?
NCT02121184 is a clinical study titled "Association Between Fluid Administration, Oxytocin Administration, and Fetal Heart Rate Changes". Fetal heart rate patterns are an important parameter in the diagnosis of non-reassuring fetal status. Combined-spinal epidural analgesia is a method of initiating labor analgesia used by approximately 90% of the parturients at Prentice Women's Hospital. Optimizing the variables which could affect fe...
What is the current status of trial NCT02121184?
This trial is currently terminated. It is a NA study. The enrollment target is 172 participants. The study started on 2014-04. Estimated completion is 2021-09-21.
What interventions are being tested in trial NCT02121184?
The interventions under investigation include: Routine oxytocin (DRUG), Half-dose oxytocin (DRUG).
Who is sponsoring clinical trial NCT02121184?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02121184's enrollment target sits among peer trials
172 612th of 2000 higher than 1,389 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia